You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康辰藥業(603590.SH):上海康辰完成認購優鋭開曼5300.93萬股D序列優先股
格隆匯 02-01 17:28

格隆匯2月1日丨康辰藥業(603590.SH)公佈,公司擬通過二級全資子公司康辰生物醫藥(上海)有限公司(以下簡稱“上海康辰”)以2500萬美元認購Nuance Biotech(以下簡稱“優鋭開曼”)新發行的5300.93萬股D序列優先股。2020年11月23日,上海康辰與本次交易共同投資人、優鋭開曼及其下屬子公司、優鋭開曼全體現有股東共同簽署《股份認購協議》。

近日,上海康辰已完成境外直接投資外匯登記。截至本公吿披露日,上海康辰已完成本次交易股份認購價款2500萬美元的支付工作,並收到優鋭開曼提供的更新的股東名冊、股份證書、交割證明等文件,本次交易已完成交割。

本次增資交割完成後,優鋭開曼根據《股份認購協議》共發行3.84億股D序列優先股,其中,上海康辰將持有優鋭開曼5300.93萬股股份,約佔增資完成後優鋭開曼總股本(全面攤薄和轉股基礎上)的5.22%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account